Amazon Launches GLP-1 Weight Program to Tap $100B Market Boom

Amazon One Medical launched a GLP-1-centered weight-management program offering prescriptions for oral Foundayo and Wegovy, virtual and in-person care, fast/same-day delivery in nearly 3,000 U.S. cities, and 24/7 renewals. This positions the tech giant to gain share in the GLP-1 market forecasted at ~$100 billion by decade's end. Motley Fool analysis is bullish on boosts to One Medical and pharmacy revenue, though limited next to AWS's ~$142 billion annual run rate. Amazon stock cited at $263.93, up 3.47%. Competitors span Eli Lilly, Novo Nordisk, Pfizer, and Viking Therapeutics.